Aarohi Sharma1, Sarah Lewis, Lisa Szatkowski. 1. UK Centre for Tobacco Control Studies and University of Nottingham Division of Primary Care, Queen's Medical Centre, Nottingham, NG7 2UH, UK.
Abstract
BACKGROUND: There are well-established socio-economic differences in the prevalence of smoking in the UK, but conventional socio-economic measures may not capture the range and degree of these associations. We have used a commercial geodemographic profiling system, Mosaic, to explore associations with smoking prevalence in a large primary care dataset and to establish whether this tool provides new insights into socio-economic determinants of smoking. METHODS: We analysed anonymised data on over 2 million patients from The Health Improvement Network (THIN) database, linked via patients' postcodes to Mosaic classifications (11 groups and 61 types) and quintiles of Townsend Index of Multiple Deprivation. Patients' current smoking status was identified using Read Codes, and logistic regression was used to explore the associations between the available measures of socioeconomic status and smoking prevalence. RESULTS: As anticipated, smoking prevalence increased with increasing deprivation according to the Townsend Index (age and sex adjusted OR for highest vs lowest quintile 2.96, 95% CI 2.92-2.99). There were more marked differences in prevalence across Mosaic groups (OR for group G vs group A 4.41, 95% CI 4.33-4.49). Across the 61 Mosaic types, smoking prevalence varied from 8.6% to 42.7%. Mosaic types with high smoking prevalence were characterised by relative deprivation, but also more specifically by single-parent households living in public rented accommodation in areas with little community support, having no access to a car, few qualifications and high TV viewing behaviour. CONCLUSION: Conventional socio-economic measures may underplay social disparities in smoking prevalence. Newer classification systems, such as Mosaic, encompass a wider range of demographic, lifestyle and behaviour data, and are valuable in identifying characteristics of groups of heavy smokers which might be used to tailor cessation interventions.
BACKGROUND: There are well-established socio-economic differences in the prevalence of smoking in the UK, but conventional socio-economic measures may not capture the range and degree of these associations. We have used a commercial geodemographic profiling system, Mosaic, to explore associations with smoking prevalence in a large primary care dataset and to establish whether this tool provides new insights into socio-economic determinants of smoking. METHODS: We analysed anonymised data on over 2 million patients from The Health Improvement Network (THIN) database, linked via patients' postcodes to Mosaic classifications (11 groups and 61 types) and quintiles of Townsend Index of Multiple Deprivation. Patients' current smoking status was identified using Read Codes, and logistic regression was used to explore the associations between the available measures of socioeconomic status and smoking prevalence. RESULTS: As anticipated, smoking prevalence increased with increasing deprivation according to the Townsend Index (age and sex adjusted OR for highest vs lowest quintile 2.96, 95% CI 2.92-2.99). There were more marked differences in prevalence across Mosaic groups (OR for group G vs group A 4.41, 95% CI 4.33-4.49). Across the 61 Mosaic types, smoking prevalence varied from 8.6% to 42.7%. Mosaic types with high smoking prevalence were characterised by relative deprivation, but also more specifically by single-parent households living in public rented accommodation in areas with little community support, having no access to a car, few qualifications and high TV viewing behaviour. CONCLUSION: Conventional socio-economic measures may underplay social disparities in smoking prevalence. Newer classification systems, such as Mosaic, encompass a wider range of demographic, lifestyle and behaviour data, and are valuable in identifying characteristics of groups of heavy smokers which might be used to tailor cessation interventions.
Authors: Louise Marston; James R Carpenter; Kate R Walters; Richard W Morris; Irwin Nazareth; Irene Petersen Journal: Pharmacoepidemiol Drug Saf Date: 2010-06 Impact factor: 2.890
Authors: Barbara Iyen-Omofoman; Richard B Hubbard; Chris J P Smith; Emily Sparks; Emma Bradley; Alison Bourke; Laila J Tata Journal: BMC Public Health Date: 2011-11-10 Impact factor: 3.295
Authors: Bob C Mulder; Marijn de Bruin; Hanneke Schreurs; Erik J C van Ameijden; Cees M J van Woerkum Journal: BMC Public Health Date: 2011-10-13 Impact factor: 3.295
Authors: Ryan J Courtney; Sundresan Naicker; Anthony Shakeshaft; Philip Clare; Kristy A Martire; Richard P Mattick Journal: Int J Environ Res Public Health Date: 2015-06-08 Impact factor: 3.390
Authors: Per Wändell; Axel C Carlsson; Xinjun Li; Danijela Gasevic; Johan Ärnlöv; Martin J Holzmann; Jan Sundquist; Kristina Sundquist Journal: Clin Rheumatol Date: 2017-01-13 Impact factor: 2.980
Authors: Katarzyna Milcarz; Teresa Makowiec-Dąbrowska; Leokadia Bak-Romaniszyn; Dorota Kaleta Journal: Int J Environ Res Public Health Date: 2017-01-27 Impact factor: 3.390
Authors: Steven S Fu; Michelle van Ryn; David Nelson; Diana J Burgess; Janet L Thomas; Jessie Saul; Barbara Clothier; John A Nyman; Patrick Hammett; Anne M Joseph Journal: Thorax Date: 2016-03-01 Impact factor: 9.139